Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Juniper Pharmaceuticals Inc (NASDAQ:JNP)

5.45
Delayed Data
As of Dec 09
 0.00 / 0.00%
Today’s Change
4.30
Today|||52-Week Range
11.96
-47.09%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$59.1M

Company Description

Juniper Pharmaceuticals, Inc., formerly Columbia Laboratories, Inc., is a pharmaceutical company that engages in the development of therapeutics that addresses unmet medical needs in women's health. Its pipeline development is funded by cash flows from its CRINONE franchise and services business. It is currently developing COL-1077, a 10% lidocaine bioadhesive gel intended as an acute use anesthetic for minimally invasive gynecological procedures. The company was founded in December 1986 and is headquartered in Boston, MA.

Contact Information

Juniper Pharmaceuticals, Inc.
31st Floor
Boston Massachusetts 02110
P:(617) 639-1500
Investor Relations:

Employees

Shareholders

Individual stakeholders3.90%
Other institutional20.44%
Mutual fund holders15.54%

Top Executives

Alicia SecorPresident, Chief Executive Officer & Director
Nikin PatelChief Operating Officer & Director
George O. ElstonChief Financial Officer, Secretary & Treasurer
Shen LukChief Scientific Officer
Bridget A. MartellChief Medical Officer